Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Japanese Journal of Clinical Oncology|August 18, 2023
An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspectiveJunya Makiyama, Kenji Ishitsuka, Wataru Munakata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[Warm autoimmune hemolytic anemia accompanied by metachronous double primary cancer]Yusuke Yamano, Junya Makiyama, Masato Araki, et al.
International Journal of Hematology|June 10, 2020
Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experienceMasayuki Kobayashi, Shohei Ando, Toyotaka Kawamata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 6, 2022
[Successful treatment of myelodysplastic syndromes complicated by myeloid sarcoma with haploidentical allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide]Takafumi Furumoto, Junya Makiyama, Eo Toriyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 11, 2018
[Hypoplastic acute promyelocytic leukemia with continuous hypocellular bone marrow after remission]Toshiki Nakamura, Junya Makiyama, Ayumi Matsuura, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2020
Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective StudyJunya Makiyama, Yoshitaka Imaizumi, Haruka Watanabe, et al.
Hematological Oncology|October 21, 2025
A Multicenter Real-World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30-Positive Adult T-Cell Leukemia-LymphomaMasahito Tokunaga, Junya Makiyama, Motoaki Shiratsuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 8, 2021
[Cooccurrence of classic Hodgkin lymphoma and multiple myeloma]Shohei Andoh, Kazuaki Yokoyama, Sanshiro Uchida, et al.
Annals of Hematology|March 26, 2025
Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groupsShigeo Fuji, Masahito Tokunaga, Atae Utsunomiya, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 5, 2014
[Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma]Hiroaki Taniguchi, Yoshitaka Imaizumi, Junya Makiyama, et al.
Pageof 4